In vivo model for mastocytosis

A comparative review

Girolamo Ranieri, Ilaria Marech, Marianna Pantaleo, Mariagrazia Piccinno, Maria Roncetti, Maddalena Mutinati, Annalisa Rizzo, Cosmo Damiano Gadaleta, Marcello Introna, Rosa Patruno, Raffaele Luigi Sciorsci

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Human mastocytosis are heterogeneous group of neoplastic diseases characterized by a different degree of uncontrolled mast cell (MC) proliferation and activation. Interestingly, human mastocytosis share several biological and clinical features with canine mast cell disorders, so called canine mast cell tumors (CMCTs). These CMCTs are the most common spontaneous cutaneous tumors found in dogs representing a valid model to study neoplastic mast cell disorders. It has been discovered that the pathological activation of c-Kit receptor (c-KitR), expressed by MCs, has been involved in the pathogenesis of neoplastic MC disorders. In this review we have focused on human mastocytosis in terms of: (i) epidemiology and classification; (ii) pathogenesis at molecular levels; (iii) clinical presentation. In addition, we have summarized animal models useful to study neoplastic MC disorders including CMCTs and murine transgenic models. Finally, we have revised therapeutic approaches mostly common in human and canine MCTs and novel tyrosine kinase inhibitors approved for CMCTs and recently translated in human clinical trials.

Original languageEnglish
Pages (from-to)159-169
Number of pages11
JournalCritical Reviews in Oncology/Hematology
Volume93
Issue number3
DOIs
Publication statusPublished - Mar 1 2015

Fingerprint

Mastocytosis
Mast Cells
Canidae
Neoplasms
Proto-Oncogene Proteins c-kit
Protein-Tyrosine Kinases
Epidemiology
Animal Models
Cell Proliferation
Clinical Trials
Dogs
Skin

Keywords

  • Animal mast cell tumors
  • C-Kit receptor
  • Human mastocytosis
  • Tyrosine kinase inhibitors (TKIs)

ASJC Scopus subject areas

  • Oncology
  • Hematology
  • Geriatrics and Gerontology
  • Medicine(all)

Cite this

Ranieri, G., Marech, I., Pantaleo, M., Piccinno, M., Roncetti, M., Mutinati, M., ... Sciorsci, R. L. (2015). In vivo model for mastocytosis: A comparative review. Critical Reviews in Oncology/Hematology, 93(3), 159-169. https://doi.org/10.1016/j.critrevonc.2014.10.010

In vivo model for mastocytosis : A comparative review. / Ranieri, Girolamo; Marech, Ilaria; Pantaleo, Marianna; Piccinno, Mariagrazia; Roncetti, Maria; Mutinati, Maddalena; Rizzo, Annalisa; Gadaleta, Cosmo Damiano; Introna, Marcello; Patruno, Rosa; Sciorsci, Raffaele Luigi.

In: Critical Reviews in Oncology/Hematology, Vol. 93, No. 3, 01.03.2015, p. 159-169.

Research output: Contribution to journalArticle

Ranieri, G, Marech, I, Pantaleo, M, Piccinno, M, Roncetti, M, Mutinati, M, Rizzo, A, Gadaleta, CD, Introna, M, Patruno, R & Sciorsci, RL 2015, 'In vivo model for mastocytosis: A comparative review', Critical Reviews in Oncology/Hematology, vol. 93, no. 3, pp. 159-169. https://doi.org/10.1016/j.critrevonc.2014.10.010
Ranieri, Girolamo ; Marech, Ilaria ; Pantaleo, Marianna ; Piccinno, Mariagrazia ; Roncetti, Maria ; Mutinati, Maddalena ; Rizzo, Annalisa ; Gadaleta, Cosmo Damiano ; Introna, Marcello ; Patruno, Rosa ; Sciorsci, Raffaele Luigi. / In vivo model for mastocytosis : A comparative review. In: Critical Reviews in Oncology/Hematology. 2015 ; Vol. 93, No. 3. pp. 159-169.
@article{d5db378891a945eabf321bac4ecdd515,
title = "In vivo model for mastocytosis: A comparative review",
abstract = "Human mastocytosis are heterogeneous group of neoplastic diseases characterized by a different degree of uncontrolled mast cell (MC) proliferation and activation. Interestingly, human mastocytosis share several biological and clinical features with canine mast cell disorders, so called canine mast cell tumors (CMCTs). These CMCTs are the most common spontaneous cutaneous tumors found in dogs representing a valid model to study neoplastic mast cell disorders. It has been discovered that the pathological activation of c-Kit receptor (c-KitR), expressed by MCs, has been involved in the pathogenesis of neoplastic MC disorders. In this review we have focused on human mastocytosis in terms of: (i) epidemiology and classification; (ii) pathogenesis at molecular levels; (iii) clinical presentation. In addition, we have summarized animal models useful to study neoplastic MC disorders including CMCTs and murine transgenic models. Finally, we have revised therapeutic approaches mostly common in human and canine MCTs and novel tyrosine kinase inhibitors approved for CMCTs and recently translated in human clinical trials.",
keywords = "Animal mast cell tumors, C-Kit receptor, Human mastocytosis, Tyrosine kinase inhibitors (TKIs)",
author = "Girolamo Ranieri and Ilaria Marech and Marianna Pantaleo and Mariagrazia Piccinno and Maria Roncetti and Maddalena Mutinati and Annalisa Rizzo and Gadaleta, {Cosmo Damiano} and Marcello Introna and Rosa Patruno and Sciorsci, {Raffaele Luigi}",
year = "2015",
month = "3",
day = "1",
doi = "10.1016/j.critrevonc.2014.10.010",
language = "English",
volume = "93",
pages = "159--169",
journal = "Critical Reviews in Oncology/Hematology",
issn = "1040-8428",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - In vivo model for mastocytosis

T2 - A comparative review

AU - Ranieri, Girolamo

AU - Marech, Ilaria

AU - Pantaleo, Marianna

AU - Piccinno, Mariagrazia

AU - Roncetti, Maria

AU - Mutinati, Maddalena

AU - Rizzo, Annalisa

AU - Gadaleta, Cosmo Damiano

AU - Introna, Marcello

AU - Patruno, Rosa

AU - Sciorsci, Raffaele Luigi

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Human mastocytosis are heterogeneous group of neoplastic diseases characterized by a different degree of uncontrolled mast cell (MC) proliferation and activation. Interestingly, human mastocytosis share several biological and clinical features with canine mast cell disorders, so called canine mast cell tumors (CMCTs). These CMCTs are the most common spontaneous cutaneous tumors found in dogs representing a valid model to study neoplastic mast cell disorders. It has been discovered that the pathological activation of c-Kit receptor (c-KitR), expressed by MCs, has been involved in the pathogenesis of neoplastic MC disorders. In this review we have focused on human mastocytosis in terms of: (i) epidemiology and classification; (ii) pathogenesis at molecular levels; (iii) clinical presentation. In addition, we have summarized animal models useful to study neoplastic MC disorders including CMCTs and murine transgenic models. Finally, we have revised therapeutic approaches mostly common in human and canine MCTs and novel tyrosine kinase inhibitors approved for CMCTs and recently translated in human clinical trials.

AB - Human mastocytosis are heterogeneous group of neoplastic diseases characterized by a different degree of uncontrolled mast cell (MC) proliferation and activation. Interestingly, human mastocytosis share several biological and clinical features with canine mast cell disorders, so called canine mast cell tumors (CMCTs). These CMCTs are the most common spontaneous cutaneous tumors found in dogs representing a valid model to study neoplastic mast cell disorders. It has been discovered that the pathological activation of c-Kit receptor (c-KitR), expressed by MCs, has been involved in the pathogenesis of neoplastic MC disorders. In this review we have focused on human mastocytosis in terms of: (i) epidemiology and classification; (ii) pathogenesis at molecular levels; (iii) clinical presentation. In addition, we have summarized animal models useful to study neoplastic MC disorders including CMCTs and murine transgenic models. Finally, we have revised therapeutic approaches mostly common in human and canine MCTs and novel tyrosine kinase inhibitors approved for CMCTs and recently translated in human clinical trials.

KW - Animal mast cell tumors

KW - C-Kit receptor

KW - Human mastocytosis

KW - Tyrosine kinase inhibitors (TKIs)

UR - http://www.scopus.com/inward/record.url?scp=84922458260&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922458260&partnerID=8YFLogxK

U2 - 10.1016/j.critrevonc.2014.10.010

DO - 10.1016/j.critrevonc.2014.10.010

M3 - Article

VL - 93

SP - 159

EP - 169

JO - Critical Reviews in Oncology/Hematology

JF - Critical Reviews in Oncology/Hematology

SN - 1040-8428

IS - 3

ER -